Stem cell injection aims to repair failing hearts in landmark trial
NCT ID NCT07496372
First seen Mar 30, 2026 · Last updated May 09, 2026 · Updated 9 times
Summary
This study tests whether injecting lab-grown heart muscle cells (HiCM-188) into the heart can help people with severe heart failure (NYHA class III-IV). About 80 adults aged 18-75 with weak hearts (LVEF ≤35%) will receive the cells during bypass surgery. The main goal is to see if they can walk farther in 6 minutes, with other goals including survival and fewer hospitalizations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
TEDA International Cardiovascular Hospital
RECRUITINGTianjin, Tianjin Municipality, 300457, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.